Usop, Salma S.

HRN: 21-84-44  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/27/2022
CEFUROXIME 750MG (VIAL)
08/27/2022
09/02/2022
IV
750
Q8
Surgical Site Infection
08/28/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
08/28/2022
09/03/2022
IV
500mg
Q8
Surgical Site Infection
Waiting Final Action 
08/28/2022
CEFTRIAXONE 1G (VIAL)
08/28/2022
09/03/2022
IV
2g
OD
Surgical Site Infection
Waiting Final Action 
09/03/2022
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
09/03/2022
09/09/2022
IVTT
3.375g
Q6
Severe Surgical Site Infection
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: